HomeGLS • NSE
add
Glenmark Life Sciences Ltd
Previous close
₹1,059.75
Day range
₹1,040.00 - ₹1,102.00
Year range
₹620.20 - ₹1,335.10
Market cap
132.65B INR
Avg Volume
152.15K
P/E ratio
31.19
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 5.07B | -14.86% |
Operating expense | 1.62B | -3.51% |
Net income | 953.16M | -19.73% |
Net profit margin | 18.80 | -5.72% |
Earnings per share | 7.75 | -20.02% |
EBITDA | 1.34B | -19.67% |
Effective tax rate | 25.22% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.46B | 0.73% |
Total assets | 30.85B | 4.47% |
Total liabilities | 5.46B | -2.65% |
Total equity | 25.38B | — |
Shares outstanding | 122.51M | — |
Price to book | 5.11 | — |
Return on assets | — | — |
Return on capital | 12.16% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 953.16M | -19.73% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2011
Website
Employees
2,014
